Close Menu

Nelson Chan
Twist Bioscience has appointed Nelson Chan to its board of directors. Chan has been an advisor to Twist for the last 18 months for the firm's DNA data storage business. Chan is also chairman of the board at Synaptics and Adesto, as well as executive chairman of HZO. He previously served as CEO of Magellan and has also held various senior management roles at SanDisk Corporation. Chan will replace Paul Conley, managing director of Paladin Capital Group, who has served on Twist's board since 2013.


David Fenstermacher

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.